Other OTC Pharmaceuticals - D-A-CH

  • D-A-CH
  • In 2024, the revenue generated in the Other OTC Pharmaceuticals market in D-A-CH amounted to US$5.32bn units.
  • It is projected that the market will experience an annual growth rate of 0.96% (CAGR 2024-2029).
  • When compared to global figures, the in the United States leads the market in terms of revenue, with US$7,171.00m units generated in 2024.
  • On a per capita basis, the revenue generated per person in D-A-CH in 2024 amounted to US$52.61 units.
  • Germany is witnessing a rise in demand for herbal remedies in the Other OTC Pharmaceuticals market.

Key regions: Europe, Germany, United States, Brazil, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in D-A-CH, consisting of Germany, Austria, and Switzerland, is experiencing steady growth due to several factors. Customer preferences in the D-A-CH region play a significant role in driving the demand for Other OTC Pharmaceuticals. Consumers in these countries have a strong preference for self-medication and over-the-counter products for minor ailments and common health issues. This preference is driven by factors such as convenience, cost-effectiveness, and the desire for immediate relief. Additionally, the availability of a wide range of OTC products in pharmacies and drugstores further encourages consumers to opt for self-treatment.Trends in the market indicate a growing demand for natural and herbal OTC remedies. Consumers in the D-A-CH region are increasingly seeking alternative and complementary medicine options for their health needs. This trend is driven by a growing awareness of the potential side effects of conventional medicines and a desire for more holistic approaches to healthcare. As a result, the market for natural and herbal OTC products is expanding, with manufacturers introducing innovative formulations and expanding their product portfolios to cater to this demand.Another trend in the market is the increasing popularity of online sales channels for OTC pharmaceuticals. E-commerce platforms and online pharmacies have gained significant traction in the D-A-CH region, offering consumers the convenience of purchasing OTC products from the comfort of their homes. This trend is driven by factors such as competitive pricing, wide product selection, and the ability to compare prices and read reviews before making a purchase. Online sales channels also provide a platform for smaller, niche OTC brands to reach a broader customer base.Local special circumstances in the D-A-CH region further contribute to the development of the Other OTC Pharmaceuticals market. Germany, Austria, and Switzerland have well-established healthcare systems with a strong emphasis on preventive care and self-management of health conditions. This healthcare culture encourages individuals to take an active role in their well-being and seek out OTC remedies for minor ailments. Additionally, the high level of disposable income in these countries enables consumers to afford OTC products and invest in their health.Underlying macroeconomic factors also play a role in the growth of the Other OTC Pharmaceuticals market in D-A-CH. The stable economies of Germany, Austria, and Switzerland, coupled with low unemployment rates, contribute to the overall purchasing power of consumers. Furthermore, the aging population in these countries drives the demand for OTC products, as older individuals often require medications for chronic conditions and age-related ailments.In conclusion, the Other OTC Pharmaceuticals market in D-A-CH is developing due to customer preferences for self-medication, the growing demand for natural and herbal remedies, the popularity of online sales channels, local special circumstances promoting self-management of health, and underlying macroeconomic factors such as stable economies and an aging population.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)